Intuitive Surgical ISRG
SEC filings (XBRL) · quarterly · fiscal year ends December 31
Pick a second metric to compare.
Source: SEC EDGAR 10-Q/10-K XBRL, CIK 1035267; every value is traced to its filing on EDGAR. Retrieved Oct 11, 2026. Quarters labelled by fiscal quarter with the calendar period end. Q4 = annual minus Q1–Q3; cash-flow quarters derived from year-to-date figures.
Last 84 quarters
| Q3 2024Sep 30, 2024 | Q4 2024Dec 31, 2024 | Q1 2025Mar 31, 2025 | Q2 2025Jun 30, 2025 | Q3 2025Sep 30, 2025 | Q4 2025Dec 31, 2025 | Q1 2026Mar 31, 2026 | Q2 2026Jun 30, 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.0B | $2.4B | $2.3B | $2.4B | $2.5B | $2.9B | $2.8B | $2.9B |
| Operating income | $0.6B | $0.7B | $0.6B | $0.7B | $0.8B | $0.9B | $0.9B | $1.0B |
| Net income | $0.6B | $0.7B | $0.7B | $0.7B | $0.7B | $0.8B | $0.8B | $0.8B |
| Capital spending | $0.2B | $0.3B | $0.1B | $0.2B | $0.1B | $0.2B | $0.1B | $0.1B |
| Operating cash flow | $0.7B | $0.8B | $0.6B | $0.7B | $0.8B | $0.9B | $0.9B | $1.1B |
| Free cash flow | $0.5B | $0.5B | $0.5B | $0.6B | $0.7B | $0.7B | $0.8B | $0.9B |
| Capex / operating cash flow | 35.1% | 37.9% | 20.1% | 21.7% | 12.5% | 18.2% | 11.3% | 10.6% |
| Shares outstanding | 356.2M | 356.7M | 358.4M | 358.5M | 354.5M | 355.1M | 354.2M | 353.3M |
| Share count change, y/y | +1.2% | +1.2% | +1.0% | +0.9% | −0.5% | −0.4% | −1.2% | −1.4% |
| Diluted shares (weighted avg.) | 362.7M | — No figure for Q4 2024: fiscal Q4: the 10-K presents no 3-month weighted average; never derived | 364.6M | 364.1M | 361.8M | — No figure for Q4 2025: fiscal Q4: the 10-K presents no 3-month weighted average; never derived | 359.8M | 357.3M |
— Diluted shares (weighted avg.): No figure for Q4 2024: fiscal Q4: the 10-K presents no 3-month weighted average; never derived
— Diluted shares (weighted avg.): No figure for Q4 2025: fiscal Q4: the 10-K presents no 3-month weighted average; never derived
Diluted shares (weighted avg.): fiscal Q4 is blank because the 10-K gives 12-month figures only.
XBRL tags used
| Revenue | RevenueFromContractWithCustomerExcludingAssessedTax | Jun 2017 to Jun 2026 |
|---|---|---|
| Operating income | OperatingIncomeLoss | Mar 2018 to Jun 2026 |
| Net income | NetIncomeLoss | Mar 2018 to Jun 2026 |
| Capital spending | PaymentsToAcquireProductiveAssets | Mar 2017 to Jun 2026 |
| Operating cash flow | NetCashProvidedByUsedInOperatingActivities | Mar 2017 to Jun 2026 |
| Free cash flow | ocf - capex: NetCashProvidedByUsedInOperatingActivities, PaymentsToAcquireProductiveAssets | Mar 2017 to Jun 2026 |
| Capex / operating cash flow | capex / ocf * 100: PaymentsToAcquireProductiveAssets, NetCashProvidedByUsedInOperatingActivities | Mar 2017 to Jun 2026 |
| Shares outstanding | dei:EntityCommonStockSharesOutstanding | Mar 2017 to Jun 2026 |
| Diluted shares (weighted avg.) | WeightedAverageNumberOfDilutedSharesOutstanding | Mar 2017 to Jun 2026 |
Where a company changed tags, each quarter uses the tag it was reported under; the newest tag is primary.